These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 18338924)
1. [Urease activity in Cryptococcus neoformans and Cryptococcus gattii]. Torres-Rodríguez JM; Alvarado-Ramírez E; Gutiérrez-Gallego R Rev Iberoam Micol; 2008 Mar; 25(1):27-31. PubMed ID: 18338924 [TBL] [Abstract][Full Text] [Related]
2. Extracellular DNase activity of Cryptococcus neoformans and Cryptococcus gattii. Sánchez M; Colom F Rev Iberoam Micol; 2010 Mar; 27(1):10-3. PubMed ID: 20167522 [TBL] [Abstract][Full Text] [Related]
3. Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans. Kwon-Chung KJ; Wickes BL; Booth JL; Vishniac HS; Bennett JE Infect Immun; 1987 Aug; 55(8):1751-4. PubMed ID: 3112009 [TBL] [Abstract][Full Text] [Related]
4. Enzymatic characterisation of clinical isolates of Cryptococcus neoformans, Cryptococcus gattii and other environmental Cryptococcus spp. Chan MY; Tay ST Mycoses; 2010 Jan; 53(1):26-31. PubMed ID: 19389064 [TBL] [Abstract][Full Text] [Related]
5. Enzymatic characterization of clinical and environmental Cryptococcus neoformans strains isolated in Italy. Pini G; Faggi E; Campisi E Rev Iberoam Micol; 2017; 34(2):77-82. PubMed ID: 28215482 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas. Andrade-Silva L; Ferreira-Paim K; Silva-Vergara ML; Pedrosa AL Fungal Biol; 2010; 114(5-6):438-45. PubMed ID: 20943154 [TBL] [Abstract][Full Text] [Related]
7. Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans. Cheng PY; Sham A; Kronstad JW Infect Immun; 2009 Oct; 77(10):4284-94. PubMed ID: 19635827 [TBL] [Abstract][Full Text] [Related]
8. [Characterization of Cryptococcus neoformans strains isolated from patients with acquired immunodeficiency syndrome (AIDS)]. Garza-Garza D; Buendía-Uribe JL; Martínez-Cruz E; Argüero-Licea B Rev Latinoam Microbiol; 1995; 37(3):273-9. PubMed ID: 8850346 [TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India. Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471 [TBL] [Abstract][Full Text] [Related]
10. Cryptococcus gattii urease as a virulence factor and the relevance of enzymatic activity in cryptococcosis pathogenesis. Feder V; Kmetzsch L; Staats CC; Vidal-Figueiredo N; Ligabue-Braun R; Carlini CR; Vainstein MH FEBS J; 2015 Apr; 282(8):1406-18. PubMed ID: 25675897 [TBL] [Abstract][Full Text] [Related]
11. Measuring Urease and Phospholipase Secretion in Cryptococcus neoformans. Hoffman HJ; McClelland EE Methods Mol Biol; 2024; 2775():269-275. PubMed ID: 38758324 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic switching of Cryptococcus neoformans and Cryptococcus gattii. Jain N; Fries BC Mycopathologia; 2008 Oct; 166(4):181-8. PubMed ID: 18568418 [TBL] [Abstract][Full Text] [Related]
14. [In vitro determination of virulence factors activity associated with several Cryptococcus neoformans clinical isolates]. Sánchez A; Escandón P; Castañeda E Rev Iberoam Micol; 2008 Sep; 25(3):145-9. PubMed ID: 18785782 [TBL] [Abstract][Full Text] [Related]
15. Identification of Cryptococcus gattii by use of L-canavanine glycine bromothymol blue medium and DNA sequencing. Klein KR; Hall L; Deml SM; Rysavy JM; Wohlfiel SL; Wengenack NL J Clin Microbiol; 2009 Nov; 47(11):3669-72. PubMed ID: 19794048 [TBL] [Abstract][Full Text] [Related]
16. Factors required for activation of urease as a virulence determinant in Cryptococcus neoformans. Singh A; Panting RJ; Varma A; Saijo T; Waldron KJ; Jong A; Ngamskulrungroj P; Chang YC; Rutherford JC; Kwon-Chung KJ mBio; 2013 May; 4(3):e00220-13. PubMed ID: 23653445 [TBL] [Abstract][Full Text] [Related]
17. [Study on genotype and virulence of Cryptococcus neoformans and Cryptococcus gattii clinical isolates in Guigang, Guangxi Zhuang Autonomous Region]. Bian F; Wu Y; Yu S; Che J; Li W; Shao Z; Zhu B; Lu J Zhonghua Liu Xing Bing Xue Za Zhi; 2015 May; 36(5):491-5. PubMed ID: 26080640 [TBL] [Abstract][Full Text] [Related]
18. Differences in nitrogen metabolism between Cryptococcus neoformans and C. gattii, the two etiologic agents of cryptococcosis. Ngamskulrungroj P; Chang Y; Roh J; Kwon-Chung KJ PLoS One; 2012; 7(3):e34258. PubMed ID: 22479580 [TBL] [Abstract][Full Text] [Related]
19. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil. Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969 [TBL] [Abstract][Full Text] [Related]
20. Farnesol inhibits in vitro growth of the Cryptococcus neoformans species complex with no significant changes in virulence-related exoenzymes. Cordeiro Rde A; Nogueira GC; Brilhante RS; Teixeira CE; Mourão CI; Castelo-Branco Dde S; Paiva Mde A; Ribeiro JF; Monteiro AJ; Sidrim JJ; Rocha MF Vet Microbiol; 2012 Oct; 159(3-4):375-80. PubMed ID: 22580194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]